Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-02 09:47:11 - browse：53

Stock exchange — Drew Angerer/Getty Images

Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medicare innovation center doesn’t save money, experts say

WSS

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

WHO recommends second malaria vaccine

A bus careens into a gulch in southern Mexico, leaving 27 people dead

What we owe ALS patients — and why one company fell short

The stability of $0 premiums in Medicare Advantage

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Activists slam private health insurers over coverage restrictions

Some top drug companies are starting to take action on climate

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pope Francis asks Church to identify 21st

After affirmative action ruling, medical educators look to 'holistic review'

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

23andMe had bad news about my health. I wish a person had delivered it

Search warrant issued in 1996 disappearance of Kristin Smart

Walensky prepares to leave CDC — and Congress — behind

China dismisses criticism of top diplomat's comments appearing to push for race

entertainment

Stop Congress from blocking public access to science

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

The Karikó problem: Lessons for funding basic research

5 shark bites reported on Long Island as officials deploy surveillance drones

2 million sign

Medicare innovation center doesn’t save money, experts say

Wikipedia

knowledge

leisure time

leisure time